Could REGEN-COV’s New US FDA Emergency Use Authorization Revive COVID-19 Prophylaxis Pipeline?

Regeneron’s neutralizing antibody cocktail earned the first post-exposure prophylaxis EUA for COVID-19, but the new use and dosing improvements need to overcome slow uptake under the original authorization for the COVID-19 treatment and the poisoned environment left by hydroxychloroquine controversies.

Prophylaxis
The post-exposure prophylaxis EUA highlighted the needs of immunocompromised patients, Regeneron's president said. • Source: Alamy

More from R&D

More from Pink Sheet